Literature DB >> 17671227

Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level.

H Martin Vordermeier1, Jemma Brown, Paul J Cockle, Willeke P J Franken, Jan Wouter Drijfhout, Sandra M Arend, Tom H M Ottenhoff, Keith Jahans, R Glyn Hewinson.   

Abstract

Cross-reactivity between Mycobacterium kansasii ESAT-6 and CFP-10 homologues and their M. bovis counterparts can confound the interpretation of immunodiagnostic tests for tuberculosis. M. kansasii is a nontuberculous mycobacterial species cultured from skin test-positive cattle in Great Britain. Using peptides derived from M. bovis and M. kansasii ESAT-6 and CFP-10 regions that differ between these species, we investigated the species specificity and cross-reactivity at the level of individual bovine T-cell epitopes. Our results demonstrated that all peptides tested are fully cross-reactive, with the exception of one ESAT-6-derived peptide that harbored an M. bovis-specific epitope(s) when it was recognized in the context of bovine leukocyte antigen (BoLA)-DQ but that was cross-reactive with its M. kansasii homologues when it was restricted by BoLA-DR. This observation further highlights that prediction of species specificity by comparing sequence identity/homology alone is not sufficient and that individuals with diverse major histocompatibility complex constellations need to be tested to characterize the cross-reactivity or species specificity of peptide-based reagents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671227      PMCID: PMC2043317          DOI: 10.1128/CVI.00116-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  32 in total

Review 1.  BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis.

Authors:  P R Wood; S L Jones
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

2.  Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare.

Authors:  C H Ahn; J W McLarty; S S Ahn; S I Ahn; G A Hurst
Journal:  Am Rev Respir Dis       Date:  1982-04

3.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family.

Authors:  Rikke Louise Vinther Skjøt; Inger Brock; Sandra M Arend; Martin E Munk; Michael Theisen; Tom H M Ottenhoff; Peter Andersen
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle.

Authors:  B M Buddle; A R McCarthy; T J Ryan; J M Pollock; H M Vordermeier; R G Hewinson; P Andersen; G W de Lisle
Journal:  Vet Rec       Date:  2003-11-15       Impact factor: 2.695

6.  The complete genome sequence of Mycobacterium bovis.

Authors:  Thierry Garnier; Karin Eiglmeier; Jean-Christophe Camus; Nadine Medina; Huma Mansoor; Melinda Pryor; Stephanie Duthoy; Sophie Grondin; Celine Lacroix; Christel Monsempe; Sylvie Simon; Barbara Harris; Rebecca Atkin; Jon Doggett; Rebecca Mayes; Lisa Keating; Paul R Wheeler; Julian Parkhill; Bart G Barrell; Stewart T Cole; Stephen V Gordon; R Glyn Hewinson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

7.  Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles.

Authors:  Homayoun Shams; Peter Klucar; Steven E Weis; Ajit Lalvani; Patrick K Moonan; Hassan Safi; Benjamin Wizel; Katie Ewer; Gerald T Nepom; David M Lewinsohn; Peter Andersen; Peter F Barnes
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii.

Authors:  Sandra M Arend; Krista E van Meijgaarden; Kirsten de Boer; Elisabeth Cerdá de Palou; Dick van Soolingen; Tom H M Ottenhoff; Jaap T van Dissel
Journal:  J Infect Dis       Date:  2002-11-19       Impact factor: 5.226

9.  Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect.

Authors:  S M Arend; E Cerdá de Palou; P de Haas; R Janssen; M A Hoeve; E M Verhard; T H M Ottenhoff; D van Soolingen; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2004-08       Impact factor: 8.067

10.  Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes.

Authors:  Martin Vordermeier; Adam O Whelan; R Glyn Hewinson
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  18 in total

Review 1.  Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).

Authors:  Tatiana I Kuznetcova; Alain Sauty; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2012-06-02       Impact factor: 2.031

2.  Use of antigen-specific interleukin-2 to differentiate between cattle vaccinated with Mycobacterium bovis BCG and cattle infected with M. bovis.

Authors:  Shelley G Rhodes; Lucy C McKinna; Sabine Steinbach; Gilly S Dean; Bernardo Villarreal-Ramos; Adam O Whelan; C Pirson; Gareth J Jones; Derek Clifford; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Culture-Independent PCR Detection and Differentiation of Mycobacteria spp. in Antemortem Respiratory Samples from African Elephants (Loxodonta Africana) and Rhinoceros (Ceratotherium Simum, Diceros Bicornis) in South Africa.

Authors:  Wynand J Goosen; Charlene Clarke; Léanie Kleynhans; Tanya J Kerr; Peter Buss; Michele A Miller
Journal:  Pathogens       Date:  2022-06-20

4.  Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Authors:  Yun-Gyoung Hur; Amelia C Crampin; Christina Chisambo; James Kanyika; Rein Houben; Richard Ndhlovu; Themba Mzembe; Maeve K Lalor; Jacky Saul; Keith Branson; Carolynne Stanley; Bagrey Ngwira; Neil French; Tom H Ottenhoff; Hazel M Dockrell; Patricia Gorak-Stolinska
Journal:  Clin Vaccine Immunol       Date:  2013-11-27

5.  Evaluation of gamma interferon and antibody tuberculosis tests in alpacas.

Authors:  Shelley Rhodes; Tom Holder; Derek Clifford; Ian Dexter; Jacky Brewer; Noel Smith; Laura Waring; Tim Crawshaw; Steve Gillgan; Konstantin Lyashchenko; John Lawrence; John Clarke; Ricardo de la Rua-Domenech; Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

6.  Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.

Authors:  Annemieke Geluk; Jolien van der Ploeg; Rose O B Teles; Kees L M C Franken; Corine Prins; Jan Wouter Drijfhout; Euzenir N Sarno; Elizabeth P Sampaio; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2008-01-16

7.  Assessment of Mycobacterium tuberculosis OmpATb as a novel antigen for the diagnosis of bovine tuberculosis.

Authors:  Irene Schiller; H Martin Vordermeier; W Ray Waters; Mitchell Palmer; Tyler Thacker; Adam Whelan; Roland Hardegger; Beatrice Marg-Haufe; Alex Raeber; Bruno Oesch
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

8.  Validation of the ALS assay in adult patients with culture confirmed pulmonary tuberculosis.

Authors:  Rokeya Sultana Rekha; S M Mostafa Kamal; Peter Andersen; Zeaur Rahim; Md Imranul Hoq; Gul Ara; Jan Andersson; David Sack; Rubhana Raqib
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  Thermal stability of self-assembled peptide vaccine materials.

Authors:  Tao Sun; Huifang Han; Gregory A Hudalla; Yi Wen; Rebecca R Pompano; Joel H Collier
Journal:  Acta Biomater       Date:  2015-11-14       Impact factor: 8.947

Review 10.  A review of risk factors for bovine tuberculosis infection in cattle in the UK and Ireland.

Authors:  J M Broughan; J Judge; E Ely; R J Delahay; G Wilson; R S Clifton-Hadley; A V Goodchild; H Bishop; J E Parry; S H Downs
Journal:  Epidemiol Infect       Date:  2016-07-25       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.